AwardTape · Defense awards · Medical · Health care services · W81XWH22D0014
W81XWH22D0014: $0 IDIQ contract to Ezbiome Inc
Ezbiome Inc holds an IDIQ contract from Defense Health Agency with $0 obligated since Oct 2023, against a ceiling of $1.1M. Latest action Apr 28, 2026.
Metagenome sequencing
| PIID | W81XWH22D0014 |
|---|---|
| Type | IDIQ contract |
| Company | Ezbiome Inc |
| Agency | Defense Health Agency |
| Contracting office | DEFENSE HEALTH AGENCY |
| Category | Medical · Health care services |
| PSC | Q301 REFERENCE LABORATORY TESTING |
| NAICS | 621511 MEDICAL LABORATORIES |
| Obligated since Oct 2023 | $0 |
| Total obligated (lifetime) | $0 |
| Ceiling (base and all options) | $1.1M |
| Base date | Sep 7, 2022 |
| Latest action | Apr 28, 2026 |
| End date | n/a |
| Actions since Oct 2023 | 4 |
| Pricing | Firm fixed price |
| Competition | Competed under simplified acquisition |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
| Award | Company | Obligated FY2024+ | What | Agency | Category | Latest action |
|---|---|---|---|---|---|---|
| HT942525F0238 delivery order | Ezbiome Inc | $133K | Metagenome sequencing services | Defense Health Agency | Health care services | Feb 6, 2026 DoD 90d |
| HT942524F0179 delivery order | Ezbiome Inc | $58K | Microbiome sequencing and analysis services | Defense Health Agency | Health care services | Jun 13, 2024 DoD 90d |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial